Creatinine Fluctuation in Patients With Lupus Nephritis: Considerations for Clinical Trial Endpoints
Lupus nephritis (LN) is a common manifestation of systemic lupus erythematosus (SLE) and a major driver of morbidity and mortality. Proliferative forms of LN are typically managed with immunosuppressive therapy, with the aim of attenuating renal inflammation and preserving kidney function.1Almaani S...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | angličtina |
| Vydáno: |
2020
|
| On-line přístup: | https://doi.org/10.1016/j.ekir.2020.05.011 http://www.kireports.org/article/S2468024920312729/pdf |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|